Latest Food and Drug Administration Stories
Auto-ID based tracking system developed as a result of a National Institute of Health STTR Grant secures FDA 510(k) pre-market clearance, SysLogic initiates transfer to S3Edge. Portland, Oregon (PRWEB) June 04, 2013 S3Edge, Inc. welcomes the announcement by the Food & Drug Administration (FDA) that iTrace for Blood Centers, the tracking system developed by the RFID Consortium has been cleared for marketing. The RFID and barcode based Blood Product Tracking system enables improved...
National network of attorneys will continue offering free consultations on new cases as Massachusetts judge now coordinating federal multidistrict litigation begins organizing consolidated cases. San Diego, CA (PRWEB) June 04, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/Dialysis-Lawsuit.html Resource4thePeople reports today to consumers that even though a judge has been assigned to oversee the consolidated federal lawsuits* alleging that NaturaLyte and GranuFlo kidney...
In response to a recent FDA inspection of 30 compounding pharmacies, Avomeen's pharmaceutical testing laboratory has strengthened their advanced pharmaceutical analysis services to assist in contaminant identification and more. Ann Arbor, Michigan (PRWEB) June 04, 2013 Since last fall’s deadly meningitis outbreak, Avomeen's pharmaceutical testing laboratory has dedicated new resources and developed new methods for the analysis of drugs from compounding pharmacies. Compounding...
Letter from health professionals urges President to pressure FDA to act on stalled antibiotics policies to protect public health. Washington, DC (PRWEB) June 04, 2013 Health Care Without Harm (HCWH), Healthy Food Action, and the Pew Charitable Trusts delivered a letter with signatures from 795 health professionals to President Barack Obama today, urging him to pressure the Food and Drug Administration (FDA) to act on stalled policies to reduce the overuse and misuse of antibiotics in food...
NEW YORK, June 4, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Pluristem Therapeutics, Inc. ("Pluristem" or the "Company") (NasdaqCM: PSTI -News). The investigation focuses on whether the Company and its executives violated federal securities laws. On Tuesday, June 4, 2013, shares of the Pluristem fell $0.47 or 14% during intraday trading after the Company said a...
BUFFALO, N.Y., June 4, 2013 /PRNewswire/ -- Kinex Pharmaceuticals, Inc. announced today, that the FDA has allowed its Investigational New Drug (IND) application for KX02, Kinex's dual src/pretubulin inhibitor for the glioblastoma setting. KX02 is partnered in the greater China territory with XiangXue Pharmaceuticals (300147.SZ) of Guangzhou, China. KX02 is Kinex's second internally developed compound to enter clinical studies and Phase I clinical protocols are being finalized...
Selected for his extensive experience, David Schroeder joins elite analytical membership. Palmyra, WI (PRWEB) June 03, 2013 David Schroeder, a microbiologist at Standard Process Inc., has been accepted into the International Association for the Advancement of High Performance Thin Layer Chromatography (HPTLC). The association collaborates on HPTLC methodology and techniques in plant analysis and other analytical fields. Schroeder gained extensive experience while developing Standard...
PHILADELPHIA, June 3, 2013 /PRNewswire/ -- TransCelerate BioPharma Inc. ("TransCelerate"), an independent non-profit organization focused on accelerating the development of new medicines, today released a position paper outlining a methodology for risk-based site monitoring ("Risk-Based Monitoring" or "RBM") that could significantly modernize and streamline the way studies are conducted and monitored. The RBM position paper reflects TransCelerate's collaborative approach to improve...
Presentation scheduled on June 6, 2013 at 3:00 p.m. ET in New York SAN DIEGO, June 3, 2013 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that Chief Executive Officer Antonius Schuh, Ph.D. is scheduled to present a corporate overview at the Jefferies 2013 Global Healthcare Conference in New York on Thursday, June 6, 2013 at 3:00 p.m. Mr. Schuh and Chief Financial Officer Stephen Zaniboni will be available for...
Nationwide team of lawyers responds to consumer claims following FDA Class 1 recall of DePuy Orthopaedics LPS Diaphyseal Knee Sleeve over reports of life-threatening side effects. San Diego, CA (PRWEB) May 31, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/depuy-knee-sleeve-lawsuits.html Resource4thePeople announced today that its national team of attorneys is now investigating claims from consumers who are alleging that they suffered serious health problems from DePuy...
Latest Food and Drug Administration Reference Libraries
The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...
